McGlone Suttner Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
McGlone Suttner Wealth Management's PFE Position: Q3 2026 in Review
McGlone Suttner Wealth Management increased its Pfizer (PFE) stake by 3.5% in Q3 2026, buying an estimated $17.6K and bringing the position to 19,486 shares worth $556K. The position accounts for 0.06% of the portfolio, ranked #123.
McGlone Suttner Wealth Management first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $623K in Q4 2022. 2,908 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- McGlone Suttner Wealth Management held 19,486 shares of Pfizer worth $556K as of Q3 2026.
- McGlone Suttner Wealth Management bought 663 Pfizer shares in Q3 2026, an estimated $17.6K.
- Pfizer made up 0.06% of McGlone Suttner Wealth Management's portfolio in Q3 2026, its #123 holding.
- McGlone Suttner Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- McGlone Suttner Wealth Management's Pfizer position peaked at $623K in Q4 2022.
- 2,908 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on McGlone Suttner Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.